Unknown

Dataset Information

0

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates.


ABSTRACT: Targeted delivery of potent cytotoxic drugs to cancer cells minimizes systemic toxicity and several side effects. NHC*-Au-Cl has already been proven to be a potent anticancer agent. In this study, we explore a strategy based on chemoselective cysteine conjugation of NHC*-Au-Cl to albumin and trastuzumab (Thiomab LC-V205C) to potentiate drug-ligand ratio, pharmacokinetics, as well as drug efficacy and safety. This strategy is a step forward towards the use of gold-based anticancer agents as targeted therapies.

SUBMITTER: Matos MJ 

PROVIDER: S-EPMC6120520 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates.

Matos Maria J MJ   Labão-Almeida Carlos C   Sayers Claire C   Dada Oyinlola O   Tacke Matthias M   Bernardes Gonçalo J L GJL  

Chemistry (Weinheim an der Bergstrasse, Germany) 20180522 47


Targeted delivery of potent cytotoxic drugs to cancer cells minimizes systemic toxicity and several side effects. NHC*-Au-Cl has already been proven to be a potent anticancer agent. In this study, we explore a strategy based on chemoselective cysteine conjugation of NHC*-Au-Cl to albumin and trastuzumab (Thiomab LC-V205C) to potentiate drug-ligand ratio, pharmacokinetics, as well as drug efficacy and safety. This strategy is a step forward towards the use of gold-based anticancer agents as targe  ...[more]

Similar Datasets

| S-EPMC7435828 | biostudies-literature
| S-EPMC8301381 | biostudies-literature
| S-EPMC3299827 | biostudies-literature
| S-EPMC3500778 | biostudies-literature
| S-EPMC5344248 | biostudies-other
| S-EPMC7689731 | biostudies-literature
| S-EPMC7476583 | biostudies-literature
| S-EPMC6268926 | biostudies-literature
2017-09-23 | GSE99978 | GEO
| S-EPMC5736135 | biostudies-literature